Department of Orthopedics Surgery, The 900th Hospital of Joint Logistic Support Force, PLA, 156 West Second Ring North Road, Gulou District, Fuzhou, 350025, Fujian Province, People's Republic of China.
Fuzong Clinical Medical College of Fujian Medical University, Fuzhou, 350025, Fujian Province, People's Republic of China.
J Orthop Surg Res. 2023 Jan 23;18(1):61. doi: 10.1186/s13018-023-03536-8.
This study aimed to explore the clinical characteristics of perioperative acute gout attacks in patients with varying uric acid levels undergoing orthopedic surgery, identify the risk factors for gout recurrence within the first postoperative year, and provide a disease prevention and diagnostic reference.
This hospital-based retrospective study was conducted between January 2018 and December 2020. According to the blood uric acid levels at admission, the patients were grouped into either the normal uric acid level group or the hyperuricemia group. Patient comorbidities, serum uric acid levels, inflammatory indicators, follow-up recurrence rates, and other indicators were compared.
The uric acid decline ratio and the inflammatory indexes (white blood cell count and C-reactive protein level) at the time of the attack were significantly higher in the normal uric acid level group than in the hyperuricemia group (P < 0.05). Patients in the hyperuricemia group with diabetes and tophi and those administered diuretics were more prone to acute gout attacks than those in the normal uric acid level group (P < 0.05). In the normal uric acid level group, 22 patients (84.6%) exhibited single joint involvement, whereas only 18 patients (47.4%) in the hyperuricemia group demonstrated single joint involvement (P < 0.05). After 1 year of follow-up, the gout recurrence rate in the hyperuricemia group was 44.7%, which was significantly higher that the recurrence rate in the normoglycemic group (11.5%; P < 0.05). Presenting tophi in perioperative orthopedic surgery patients was found to be an independent risk factor for gout recurrence within 1 year (RR = 4.80; P = 0.029).
The recurrence rate of gout in patients with hyperuricemia during perioperative period increased 1 year after operation. Therefore, it is crucial to monitor the uric acid level to prevent acute gout attacks during the perioperative period and recurrence during the 1-year follow-up period. Moreover, the risk of an acute gout recurrence 1 year after operation increased in patients who presented tophi; therefore, it is necessary to maintain appropriate blood uric acid level during perioperative period among patients undergoing orthopedic surgery.
本研究旨在探讨不同血尿酸水平的骨科手术患者围手术期急性痛风发作的临床特征,明确术后 1 年内痛风复发的风险因素,为疾病的预防和诊断提供参考。
本回顾性医院队列研究于 2018 年 1 月至 2020 年 12 月期间开展。根据入院时血尿酸水平,将患者分为血尿酸正常组和高尿酸血症组。比较两组患者的合并症、血尿酸水平、炎症指标、随访复发率等指标。
血尿酸正常组的尿酸下降率和炎症指标(白细胞计数和 C 反应蛋白水平)在发作时明显高于高尿酸血症组(P<0.05)。高尿酸血症组中合并糖尿病和痛风石以及使用利尿剂的患者发生急性痛风发作的风险高于血尿酸正常组(P<0.05)。在血尿酸正常组中,22 例(84.6%)患者表现为单关节受累,而高尿酸血症组中仅有 18 例(47.4%)患者表现为单关节受累(P<0.05)。在 1 年随访后,高尿酸血症组的痛风复发率为 44.7%,明显高于血尿酸正常组的 11.5%(P<0.05)。在围手术期骨科手术患者中出现痛风石被认为是术后 1 年内痛风复发的独立危险因素(RR=4.80;P=0.029)。
围手术期高尿酸血症患者术后 1 年的痛风复发率增加。因此,在围手术期监测血尿酸水平以预防急性痛风发作和 1 年随访期间的复发至关重要。此外,术后 1 年有痛风复发风险的患者,在围手术期出现痛风石;因此,有必要在围手术期保持适当的血尿酸水平。